. Author manuscript; available in PMC: 2026 Jun 1.

Published in final edited form as: Pregnancy Hypertens. 2025 May 8;40:101221. doi: 10.1016/j.preghy.2025.101221

Table 2.

Coagulation factor levels in study subjects with a history of preterm preeclampsia and controls

Coagulation Factor, % of Mean Population Avg ± S.D.	PreP Group (n=17)	NL Group (n=68)	P-value
Pro-coagulant
II	103.0 ± 13.8	91.5 ± 12.8	.002
V	97.4 ± 17.4	83.6 ± 14.6	.001
VII	112.0 ± 32.8	95.9 ± 24.7	.03
VIII	92.3 ± 23.0	99.6 ± 31.2	0.37
IX	119.9 ± 23.0	91.7 ± 19.7	<.001
X	102.7 ± 17.7	93.3 ± 14.5	.03
XI	116.8 ± 28.0	91.8 ± 25.8	<.001
XII	113.3 ± 25.1	103.7 ± 26.0	0.17
Anticoagulants
PC	142.4 ± 32.2	112.0 ± 20.7	<.001